MedPath

Intraoperative Sedatives and Postoperative Pain

Phase 4
Completed
Conditions
Arthritis, Degenerative
Interventions
Registration Number
NCT02784626
Lead Sponsor
Seoul National University Bundang Hospital
Brief Summary

In this study, based on the hypothesis that dexmedetomidine administered intraoperatively for sedation can reduce postoperative pain than that of propofol, the investigators examined the ability of dexmedetomidine to reduce postoperative pain in in patients undergoing the total knee arthroplasty.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
48
Inclusion Criteria
  • Patients undergoing total knee arthroplasty
  • Age: 20 - 80 yrs
Read More
Exclusion Criteria
  • ASA classification ≥ 3
  • Patient who do not want sedation during the surgery
  • Patient who wants general anesthesia
  • Cardiovascular disease
  • Liver dysfunction
  • Renal dysfunction
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
DexmedetomidineDexmedetomidinePatients who received dexmedetomidine during the operation
PropofolPropofolPatients who received propofol during the operation
Primary Outcome Measures
NameTimeMethod
Visual analogue scalePostoperative 24 hours

Postoperative pain score at postoperative 24 hours

Secondary Outcome Measures
NameTimeMethod
Rescue analgesicsPostoperative 48 hours

Amount of rescue analgesics administered during 48 hours postoperatively

Visual analogue scalePostoperative 48 hours

Postoperative pain score at postoperative 48 hours

Trial Locations

Locations (1)

Seoul National University Bundang Hospital

🇰🇷

Seongnam-si, Gyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath